Search

Your search keyword '"Biomarkers, Tumor genetics"' showing total 55,420 results

Search Constraints

Start Over You searched for: Descriptor "Biomarkers, Tumor genetics" Remove constraint Descriptor: "Biomarkers, Tumor genetics"
55,420 results on '"Biomarkers, Tumor genetics"'

Search Results

1. Machine learning approach to predict blood-secretory proteins and potential biomarkers for liver cancer using omics data.

2. Construction of a prognostic model for colon cancer by combining endoplasmic reticulum stress responsive genes.

3. The discrepancy of somatic BRCA1/2 pathogenic variants from two different platforms in epithelial ovarian, fallopian tube, and peritoneal cancer.

4. Ultrasensitive Amplification-Free Quantification of a Methyl CpG-Rich Cancer Biomarker by Single-Molecule Kinetic Fingerprinting.

5. A novel risk score model of lactate metabolism for predicting outcomes and immune signatures in acute myeloid leukemia.

6. A study of the clinical significance of mSEPT9 in monitoring recurrence and prognosis in patients with surgically treated colorectal cancer.

7. Expression of lipid-metabolism genes is correlated with immune microenvironment and predicts prognosis of hepatocellular carcinoma.

8. Development and verification of a novel risk model related to ubiquitination linked with prognosis and therapeutic response in clear cell renal cell carcinoma.

9. Comprehensive analysis of clinical features, mRNA splicing, and immunological role of REEP5 in esophageal squamous cell carcinoma.

10. A novel methylation-detection panel for HPV associated high-grade squamous intraepithelial lesion and cervical cancer screening.

11. Development and validation of a novel endoplasmic reticulum stress-related lncRNAs signature in osteosarcoma.

12. Detection of PIK3CA hotspot mutations in canine mammary tumors using droplet digital PCR: tissue validation and liquid biopsy feasibility.

13. Differential cellular communication in tumor immune microenvironment during early and advanced stages of lung adenocarcinoma.

14. Comparative Analysis of MYB Expression by Immunohistochemistry and RNA Sequencing in Clinical Gene Fusion Detection in Adenoid Cystic Carcinoma.

15. Study on correlation between CXCL13 and prognosis and immune characteristics of ovarian cancer.

16. Unveiling novel prognostic biomarkers and therapeutic targets for HBV-associated hepatocellular carcinoma through integrated bioinformatic analysis.

17. Identification of exosomal ceRNA networks as prognostic markers in clear cell renal cell carcinoma.

18. RNA-seq validation of microRNA expression signatures for precision melanoma diagnosis and prognostic stratification.

19. Multi-omics analysis identifies PTTG1 as a prognostic biomarker associated with immunotherapy and chemotherapy resistance.

20. Circadian rhythm genes contribute to the prognosis prediction and potential therapeutic target in gastric cancer.

21. Identification and validation of M2 macrophage-related gene signature as a novel prognostic model for head and neck squamous cell carcinoma.

22. Comprehensive pan-cancer analysis reveals ENC1 as a promising prognostic biomarker for tumor microenvironment and therapeutic responses.

23. Identification of molecular subtypes based on bile acid metabolism in cholangiocarcinoma.

24. Single‑cell RNA sequencing reveals heterogeneity in ovarian cancer and constructs a prognostic signature for prognostic prediction and immunotherapy.

25. SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression.

26. Construction of an autophagy-related genes risk model as predicting prognosis: BAG1 suppresses growth of clear cell renal cell carcinoma.

27. ALG3 predicts poor prognosis and increases resistance to anti-PD-1 therapy through modulating PD-L1 N-link glycosylation in TNBC.

28. Ubiquitin-related gene markers predict immunotherapy response and prognosis in patients with epithelial ovarian carcinoma.

29. The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer.

30. PTPN11 is a potential biomarker for type 2 diabetes mellitus complicated with colorectal cancer.

31. Identification of SLC31A1 as a prognostic biomarker and a target for therapeutics in breast cancer.

32. Higher risk of recurrence in early-stage breast cancer patients with increased levels of ribosomal protein S6.

33. Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models.

34. CD70 is a potential prognostic marker and significantly regulates cellular function in diffuse large B-cell lymphoma.

35. SASS6 promotes tumor proliferation and is associated with TP53 and immune infiltration in lung adenocarcinoma.

36. Roles of miR-20a-5p in breast cancer based on the clinical and multi-omic (CAMO) cohort and in vitro studies.

37. Single-cell omics and machine learning integration to develop a polyamine metabolism-based risk score model in breast cancer patients.

38. A prospective diagnostic model for breast cancer utilizing machine learning to examine the molecular immune infiltrate in HSPB6.

39. Systemic longitudinal immune profiling identifies proliferating Treg cells as predictors of immunotherapy benefit: biomarker analysis from the phase 3 CONTINUUM and DIPPER trials.

40. Epigenome-wide analysis across the development span of pediatric acute lymphoblastic leukemia: backtracking to birth.

41. Prognosis prediction via histological evaluation of cellular heterogeneity in glioblastoma.

42. C6 and KLRG2 are pyroptosis subtype-related prognostic biomarkers and correlated with tumor-infiltrating lymphocytes in lung adenocarcinoma.

43. Cancer treatment monitoring using cell-free DNA fragmentomes.

44. GLO1 regulates hepatocellular carcinoma proliferation and migration through the cell cycle pathway.

45. Screening differentially expressed proteins to distinguish thymoma (B1 and B3) from thymic cysts based on tandem mass tag (TMT) technology.

46. Clinical impact of large genomic explorations at diagnosis in 198 pediatric solid tumors: a monocentric study aiming practical feasibility of precision oncology.

47. Integrating machine learning and bioinformatics approaches for identifying novel diagnostic gene biomarkers in colorectal cancer.

48. Expression and role of CNIH2 in prostate cancer.

49. Cell-free DNA end characteristics enable accurate and sensitive cancer diagnosis.

50. Special Issue: "Molecular Signatures of Gynecological Cancers-Breast Cancer, Ovarian Cancer, Cervical Cancer, and Endometrial Cancer 2.0".

Catalog

Books, media, physical & digital resources